EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Off-target anti-leukemic effects of antibiotics: mechanisms and therapeutic insights

Jason Charamis, Nikolaos Katzilakis, Eftichia Stiakaki, Ioannis Kyriakidis

Cancer Chemotherapy and Pharmacology · 06.07.2026 · 96 (1)

DOI: 10.1007/s00280-026-04916-7 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancer Chemotherapy and Pharmacology, online erschienen am 06.07.2026. Verfasst von Jason Charamis und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation, Academy of Athens, Athens, 11527, Greece. Hauptthemen laut MEDLINE: Leukemia, Anti-Bacterial Agents, Antibiotics, Antineoplastic. Die Arbeit nennt 227 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Crete.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotics are among the transformative advances in medicine, but many interact with mammalian cellular targets and pathways beyond their antimicrobial activity. A clinically important expression of these off-target effects is hematologic toxicity, including immune-mediated cytopenias and direct bone marrow suppression. This narrative review examines whether the same biology that injures normal hematopoietic cells can, in selected contexts, reveal therapeutically exploitable vulnerabilities in leukemia. We synthesize molecular, clinical, and preclinical evidence and organize it into an integrative framework linking mitochondrial translation inhibition, mitonuclear imbalance, oxidative phosphorylation failure, reactive oxygen species generation, DNA/topoisomerase stress, autophagy and lysosomal-flux blockade, and apoptosis modulation with both hematotoxicity and antileukemic activity. The strongest preclinical evidence supports selected tetracyclines, macrolides, and oxazolidinones, whereas evidence for beta-lactams, glycopeptides, polymyxins, rifamycins, fluoroquinolones, and folate-pathway agents remains more limited or largely hypothesis-generating. Importantly, antibiotic-induced cytopenia should not be interpreted as proof of leukemia selectivity: immune-mediated toxicity, supratherapeutic in vitro exposure, normal progenitor injury, pharmacokinetic constraints, microbiome effects, and resistance mechanisms all narrow the translational window. Overall, antibiotic hematotoxicity is best viewed as a biologically informative signal that can guide mechanism-based repurposing and combination strategies, but clinical development requires rigorous pharmacokinetic/pharmacodynamic validation, normal hematopoietic comparators, and biomarker-driven patient selection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LeukemiaAnti-Bacterial AgentsAntibiotics, AntineoplasticHumansAnimalsCytopenia

Stichwörter der Autor:innen

AntibioticsDrug interactionsDrug side effectHematologic toxicityLeukemiaRibosome

Substanzen

Anti-Bacterial AgentsAntibiotics, Antineoplastic

Autor:innen und Institutionen

  • Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation, Academy of Athens, Athens, 11527, Greece.
  • Department of Pediatric Hematology-Oncology & Autologous Hematopoietic Stem Cell Transplantation Unit, University Hospital of Heraklion & Laboratory of Blood Diseases and Childhood Cancer Biology, School of Medicine, Un…
  • Section of Biochemistry, Molecular Biology, Cellular and Developmental Biology, Department of Biology, University of Crete, Heraklion, 70013, Greece. kyriakidis@med.uoc.gr.

Förderung

  • University of Crete

Zitieren

APA

Charamis, J., Katzilakis, N., Stiakaki, E., & Kyriakidis, I. (2026). Off-target anti-leukemic effects of antibiotics: mechanisms and therapeutic insights. Cancer Chemotherapy and Pharmacology, 96(1). https://doi.org/10.1007/s00280-026-04916-7

Vancouver

Charamis J, Katzilakis N, Stiakaki E, Kyriakidis I. Off-target anti-leukemic effects of antibiotics: mechanisms and therapeutic insights. Cancer Chemotherapy and Pharmacology. 2026;96(1). doi:10.1007/s00280-026-04916-7

BibTeX
@article{Charamis2026,
  author = {Charamis, Jason and Katzilakis, Nikolaos and Stiakaki, Eftichia and Kyriakidis, Ioannis},
  title = {Off-target anti-leukemic effects of antibiotics: mechanisms and therapeutic insights},
  journal = {Cancer Chemotherapy and Pharmacology},
  year = {2026},
  volume = {96},
  number = {1},
  doi = {10.1007/s00280-026-04916-7}
}
Kostenlos starten →